recombinant plasminogen activator inhibitor-1 compounds (University of Rochester)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant plasminogen activator inhibitor-1 compounds (University of Rochester)
Drug Alias NamerPAI-1 compounds (University of Rochester)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPlasminogen activator inhibitor 1 modulators
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsAcute Lung InjuryPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Rochester
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Rochester
Active IndicationsN/A
Inactive IndicationsAcute Lung InjuryPneumonia

Other Information

ATC CodeN/A
Related LinksN/A